|
|
|||||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Mon., May. 20, 6:05 PM
|
||||||||||||||||||||||||||||||||||||||||||
| This Slide: #1 of 25 |
Company:
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)
Date announced:
5/20/2013
Shares Offered:
6,000,000
Secondary Offering Details:
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares in the offering are to be sold by NPS. J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers for the proposed offering. NPS intends to grant the underwriters a 30-day option to purchase up to 900,000 additional shares of its common stock to cover over-allotments, if any. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
NPS Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of orphan products for patients with rare gastrointestinal and endocrine disorders and unmet medical needs. Co.'s key clinical programs involve two proprietary therapeutic peptides to restore or replace biological function: Gattex® (teduglutide) and Natpara (recombinant human parathyroid hormone 1-84). In addition, Co. has two earlier stage calcilytic compounds, NPSP790 and NPSP795, both with potential application in rare endocrine disorders, as well as a royalty-based portfolio of marketed products and products in development.
Open the NPSP Page at The Online Investor »
|
|||||||||||||||||||||
Open the NPSP Page at The Online Investor (in a new window) »
List of Secondary Stock Offerings in this Slideshow:
5/13/2013:
Company: AXIS Capital Holdings Limited (AXS)
Shares Offered: 8,000,000
More: offering details »
5/13/2013:
Company: Trade Street Residential, Inc. (TSRE)
Shares Offered: 6,250,000
More: offering details »
5/14/2013:
Company: Five Below, Inc. (FIVE)
Shares Offered: 8,563,172
More: offering details »
5/14/2013:
Company: Blackstone Mortgage Trust, Inc. (BXMT)
Shares Offered: 16,000,000
More: offering details »
5/14/2013:
Company: Ladenburg Thalmann Financial Services Inc (LTS)
More: offering details »
5/14/2013:
Company: Power Solutions International, Inc. (PSIX)
Shares Offered: 1,700,000
More: offering details »
5/14/2013:
Company: Standard Pacific Corp. (SPF)
Shares Offered: 20,000,000
More: offering details »
5/14/2013:
Company: ACADIA Pharmaceuticals Inc. (ACAD)
Shares Offered: 8,000,000
More: offering details »
5/14/2013:
Company: Rockwell Medical, Inc. (RMTI)
More: offering details »
5/14/2013:
Company: Apollo Investment Corporation (AINV)
Shares Offered: 19,000,000
More: offering details »
5/14/2013:
Company: Diamondback Energy, Inc. (FANG)
Shares Offered: 4,500,000
More: offering details »
5/14/2013:
Company: Rockwell Medical, Inc. (RMTI)
Shares Offered: 11,475,410
More: offering details »
5/15/2013:
Company: Cyclacel Pharmaceuticals, Inc. (CYCC)
More: offering details »
5/15/2013:
Company: Tesla Motors, Inc. (TSLA)
Shares Offered: 2,703,027
More: offering details »
5/15/2013:
Company: Customers Bancorp, Inc. (CUBI)
Shares Offered: 5,373,134
More: offering details »
5/15/2013:
Company: PGT, Inc. (PGTI)
Shares Offered: 10,000,000
More: offering details »
5/17/2013:
Company: Stemline Therapeutics, Inc. (STML)
Shares Offered: 4,137,931
More: offering details »
5/20/2013:
Company: Callon Petroleum Company (CPE)
More: offering details »
5/20/2013:
Company: Oaktree Capital Group, LLC (OAK)
Shares Offered: 6,000,000
More: offering details »
5/20/2013:
Company: Ironwood Pharmaceuticals, Inc. (IRWD)
Shares Offered: 10,500,000
More: offering details »
5/20/2013:
Company: The Laclede Group (LG)
Shares Offered: 8,700,000
More: offering details »
5/20/2013:
Company: First Potomac Realty Trust (FPO)
Shares Offered: 6,000,000
More: offering details »
5/20/2013:
Company: TCP Capital Corp. (TCPC)
Shares Offered: 4,000,000
More: offering details »
5/20/2013:
Company: Cimatron Limited (CIMT)
More: offering details »
5/20/2013:
Company: NPS Pharmaceuticals, Inc. (NPSP)
Shares Offered: 6,000,000
More: offering details »
Trade NPSP Now: |
Buy (3.39 out of 4) 74th percentile
(ranked higher than approx. 74% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |